Results 21 to 30 of about 227,175 (284)

Reforming the World Health Organization’s Essential Medicines List

JAMA, 2022
This Viewpoint proposes restructuring the WHO Essential Medicines List to remove consideration of cost and cost-effectiveness from the expert committee reviews of clinical effectiveness, safety, and public health value, and chartering a new framework for pooled global negotiation and procurement of costly medicines included in the list.
Hwang, Thomas J, Kesselheim, Aaron S, Vokinger, Kerstin N   +2 more
openaire   +2 more sources

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition). [PDF]

Biomed Res Int, 2018
Objective. To explore the safety of the essential medicines recorded in China’s list through the comparison of the list of essential medicines of China and the World Health Organization (WHO), as well as the analysis of the basic situation and characteristics of adverse drug reactions (ADRs) on the two essential medicines recorded in China’s and WHO ...
Zheng F, Chen H, Chen Y, Ye L, Wu H.
europepmc   +3 more sources

Assessing variation among the national essential medicines lists of 21 high-income countries: a cross-sectional study

BMJ Open, 2021
Objective Essential medicines lists have been created and used globally in countries that range from low-income to high-income status. The aim of this paper is to compare the essential medicines list of high-income countries with each other, the WHO’s ...
Nav Persaud, Michael Sergio Taglione
doaj   +1 more source

The case for an essential medicines list for Canada. [PDF]

CMAJ, 2016
Unlike 117 other member countries of the World Health Organization (WHO), Canada has no essential medicines list.[1][1] Many might argue that Canada, as a wealthy country, has no need of one. Should all countries have lists of priority medications that ought to be reliably available, or is this ...
Eom G, Grootendorst P, Duffin J.
europepmc   +4 more sources

Evaluation of Antibiotic Use in Kazakhstan for the Period 2017–2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019)

Antibiotics, 2021
The purpose of this study is to conduct a comparative analysis of the consumption of antibiotics for systemic use reimbursed by the state in Kazakhstan for 2017–2019 with the Access, Watch, and Reserve classification (AWaRe 2019) of the World Health ...
Gulzira Zhussupova, Dinara Utepova, Galiya Orazova, Saule Zhaldybayeva, Galina Skvirskaya, Kanat Tossekbayev   +5 more
doaj   +1 more source

Development of a preliminary essential medicines list for Canada. [PDF]

CMAJ Open, 2017
Some evidence supports the use of a short list of essential medicines to improve prescribing. We aimed to create a preliminary essential medicines list for use in Canada.The 2013 World Health Organization Model List of Essential Medicines was initially adapted by the research team.
Taglione MS, Ahmad H, Slater M, Aliarzadeh B, Glazier RH, Laupacis A, Persaud N.   +6 more
europepmc   +4 more sources

25 years of the WHO essential medicines lists: progress and challenges. [PDF]

, 2003
The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in international public health. The list helped to establish the principle that some medicines were more useful than others and that essential medicines were ...
't Hoen, 't Hoen, Andy Gray, Brenda Waning, Chetley, Editorial, Ellen 't Hoen, Executive Board, Gray, Gray, Gray, Hogerzeil, Howard, Kanji, Maritoux, Nathan Ford, Quick, Quick, Richard Laing, Scholtz, Steiger, Trouiller, Velasquez   +22 more
core   +1 more source

List of essential medicines for Canada [PDF]

Canadian Medical Association Journal, 2017
The articles by Morgan and colleagues in CMAJ, [1][1] and Taglione and colleagues in CMAJ Open [2][2] are useful prompts for resolving the continuing conjoint debates about a national list of essential medicines and a national pharmacare program in Canada.
openaire   +2 more sources

Legislating for universal access to medicines : a rights-based cross-national comparison of UHC laws in 16 countries [PDF]

, 2019
Universal health coverage (UHC) aims to ensure that all people have access to health services including essential medicines without risking financial hardship. Yet, in many low- and middle-income countries (LMICs) inadequate UHC fails to ensure universal
Alexandrov, Nikita V, Hogerzeil, Hans V, Perehudoff, Katrina   +2 more
core   +1 more source

In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping Sickness [PDF]

, 2012
Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to use, expensive (eflornithine monotherapy), or toxic, and ...
A Stanghellini, Andrea Kuemmerle, C Burri, C Schmid, Caecilia Schmid, Digas Tete, E Matovu, F Chappuis, F Checchi, G Priotto, G Priotto, G Priotto, Ismael Lumpungu, J Blum, J Blum, J Pepin, J Robays, JA Blum, Johannes Blum, Joseph Mathu Ndung'u, M Balasegaram, Mays Kisala, Medard Ilunga, Nono Mubwa, Olaf Valverde Mordt, Pathou Nganzobo, PP Simarro, Salah Ghabri, Severine Blesson, Sylvain Mutanda, Victor Kande, Wilfried Mutombo   +31 more
core   +3 more sources